![](images/logo.png?v=2)
International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Reviewer Referral Program
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
WSMCDD-2025
Conferences Published ↓
RBS:RH-COVID-19 (2023)
ICMRS'23
PIPRDA-2023
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 6 Issue 4
July-August 2024
Indexing Partners
![Academia.edu Academia](images/index-partners/academia.png)
![Advanced Sciences Index Advanced Sciences Index](images/index-partners/advanced-sciences.png)
![Bielefeld Academic Search Engine Bielefeld Academic Search Engine](images/index-partners/bielefeld.gif)
![CiteSeer CiteSeer](images/index-partners/cite-seer.png)
![DRJI DRJI](images/index-partners/drji.png)
![Google Scholar Google Scholar](images/index-partners/google-scholar.png)
![Independent Search Engine & Directory Network (isedn.org) Independent Search Engine & Directory Network](images/index-partners/isedn.jpg)
![ISI (International Scientific Indexing) ISI (International Scientific Indexing)](images/index-partners/isi.png)
![Issuu Issuu](images/index-partners/issuu.png)
![Mendeley Research Networks Mendeley Research Networks](images/index-partners/mendeley.png)
![RefSeek RefSeek](images/index-partners/ref-seek.png)
![ResearcherId - Thomson Reuters ResearcherId - Thomson Reuters](images/index-partners/researcher-id.png)
![ResearchGate ResearchGate](images/index-partners/research-gate.png)
![Scirus Scirus](images/index-partners/scirus.png)
![Scribd Scribd](images/index-partners/scribd.gif)
![Semantic Scholar Semantic Scholar](images/index-partners/semantic-scholar.png)
![UTeM - Universiti Teknikal Malaysia Melaka UTeM - Universiti Teknikal Malaysia Melaka](images/index-partners/utem.png)
![Wiki for Call for Papers Wiki for Call for Papers](images/index-partners/wiki-cfp.png)
![WorldCat WorldCat](images/index-partners/world-cat.png)
Future Directions of AI In Pharma : Innovation In Pharmaceutical Industry
Author(s) | Priyanka B. Wanjul, Sudarshan Parshuram Mourya, Vaibhav Laxman Gangad |
---|---|
Country | India |
Abstract | Artificial Intelligence (AI) is a technology that simulates human intelligence and problem-solving processes. It encompasses human cognitive functions such as reading, observation, preparation, interpretation, reasoning, correction, speech recognition, linguistics, and other sources. AI simplifies tasks by allowing machines to learn from past experiences, map efforts and actions to results, identify errors, correct them, adjust to new and random input values, and perform human-like tasks through in-depth scenario analysis. AI simplifies work by analyzing, filtering, sorting, predicting, scoping, and determining large data volumes to follow the best implementation procedures for producing an optimal solution. In the pharmaceutical industry, AI has several applications, including discovery and development of new drugs for complex and rare diseases such as Alzheimer's and Parkinson's, drug adherence and dosage, producing better analytics, finding more reliable patients faster for clinical trials, introducing automated robot pharmacies to fill prescriptions and dispensing, and improving marketing, logistics, and supply chain processes. AI has the potential to cut costs, create new, effective treatments, and, above all, save lives. Biotech companies should start using AI to their advantage as soon as possible. The industry has a lot to gain from embracing AI and machine learning solutions. AI can help create a strong, sustainable pipeline of new medicines faster and at reduced costs using the power of modern supercomputers and machine learning. This article exhaustively reviews the present status and future prospects of AI in pharmaceutical sciences with specific attention to the pharmaceutical industry. The literature has been collected from Pubmed, Google Scholar, and commercial websites related to this field. Overall, the future lies in cooperation between humans and machines, and alongside technological advances. Human clinical experts will need to adapt, learn, and grow. Potential experts will have to be both medical and technology experts. However, it is the evolution of medicine, not extinction. |
Keywords | Artificial intelligence, pharmaceutical science, R&D, drug discovery, disease, machine learning, Therapeutics, Medicine, Clinical trials |
Field | Medical / Pharmacy |
Published In | Volume 5, Issue 3, May-June 2023 |
Published On | 2023-05-19 |
Cite This | Future Directions of AI In Pharma : Innovation In Pharmaceutical Industry - Priyanka B. Wanjul, Sudarshan Parshuram Mourya, Vaibhav Laxman Gangad - IJFMR Volume 5, Issue 3, May-June 2023. DOI 10.36948/ijfmr.2023.v05i03.3098 |
DOI | https://doi.org/10.36948/ijfmr.2023.v05i03.3098 |
Short DOI | https://doi.org/gr9r44 |
Share this
E-ISSN 2582-2160
![](images/ean-13-barcode.gif)
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
![](images/loading.gif)